je.st
news
Valeant boosts offer for Salix Pharma to about $11.11B
2015-03-16 14:06:50| Biotech - Topix.net
Valeant is raising its offer for Salix Pharmaceuticals to about $11.11 billion, heating up a bidding fight for the company. The Canadian drug maker's new bid is for $173 per Salix share, a 2 percent premium over Friday closing price of $169.40.
Tags: offer
pharma
boosts
salix
Category:Biotechnology and Pharmaceuticals